Close Menu

IQvia

NEW YORK (GenomeWeb News) – Global Genomics Group and Quintiles announced today a collaboration aimed at developing new diagnostic tools and treatments for cardiovascular diseases as part of the Genetic Loci and Burden of Atherosclerotic Lesions (GLOBAL) clinical study.

Early-access customers of a new sample loading device that Pacific Biosciences launched last week say that the upgrade improves results for certain samples, reduces contamination, and cuts down the amount of library material required per run.

NeoGenomics Launches Test to Gauge SF3B1 Mutations, Track Chronic Lymphocytic Leukemia Progression

Genomics services provider Expression Analysis will gain access to "unsurpassed global resources" and will be able to "close strategic relationships" with leading biopharmaceutical companies by becoming part of Quintiles, EA CEO Steve McPhail said this week.

NEW YORK (GenomeWeb News) – Biopharmaceutical services and clinical research organization Quintiles today said that it has acquired genomic services provider Expression Analysis.

NEW YORK (GenomeWeb News) – Expression Analysis has netted a $27 million contract from the Environmental Protection Agency to investigate toxicology-related RNA biomarkers for a set of up to 12,100 compounds in 121,100 biological samples being reviewed under EPA's ToxCast program, EA said today.

Expression Analysis is partnering with biotechnology firm HemoShear to generate and analyze RNA information from several thousand human samples that will populate a drug database that HemoShear is developing.

NEW YORK (GenomeWeb News) – HemoShear today announced a partnership with Expression Analysis to develop a database for evaluating the vascular pharmacology of new drug compounds.

Vermillion has nominated Paul Sohmer to stand for election to its board of directors at the company's upcoming board meeting.

Expression Analysis announced yesterday that it has teamed up with Illumina and Golden Helix on an RNA-seq grant program.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.